lncRNA CASC2 Enhances 131I Sensitivity in Papillary Thyroid Cancer by Sponging miR-155
出版年份 2020 全文链接
标题
lncRNA CASC2 Enhances 131I Sensitivity in Papillary Thyroid Cancer by Sponging miR-155
作者
关键词
-
出版物
Biomed Research International
Volume 2020, Issue -, Pages 1-12
出版商
Hindawi Limited
发表日期
2020-10-20
DOI
10.1155/2020/7183629
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- miR‐155 increases stemness and decitabine resistance in triple‐negative breast cancer cells by inhibiting TSPAN5
- (2020) La‐Wei Yang et al. MOLECULAR CARCINOGENESIS
- Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway
- (2019) Fei Huang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Long non-coding RNA CASC2 serves as a ceRNA of microRNA-21 to promote PDCD4 expression in oral squamous cell carcinoma
- (2019) Lina Pan et al. OncoTargets and Therapy
- Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma
- (2019) Nasrin Rastgoo et al. HAEMATOLOGICA
- Long non-coding RNA CASC2 regulates Sprouty2 via functioning as a competing endogenous RNA for miR-183 to modulate the sensitivity of prostate cancer cells to docetaxel
- (2018) Weiyin Gao et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Long non-coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA-145 to regulate RAD18 expression
- (2018) Ying Chen et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- LncRNA MEG3 enhances 131 I sensitivity in thyroid carcinoma via sponging miR-182
- (2018) Yang Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- MiR-185 enhances radiosensitivity of colorectal cancer cells by targeting IGF1R and IGF2
- (2018) Saeid Afshar et al. BIOMEDICINE & PHARMACOTHERAPY
- Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers
- (2018) Carolyn M Klinge ENDOCRINE-RELATED CANCER
- 131 I radiation exposure and thyroid cancer
- (2018) Talha Khan Burki LANCET ONCOLOGY
- MicroRNA-320 Enhances Radiosensitivity of Glioma Through Down-Regulation of Sirtuin Type 1 by Directly Targeting Forkhead Box Protein M1
- (2018) Tengfei Li et al. Translational Oncology
- MicroRNA-155 increases colon cancer chemoresistance to cisplatin by targeting forkhead box O3
- (2018) Yuewen Gao et al. Oncology Letters
- LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway
- (2018) Tao Zhou et al. Cancer Biomarkers
- Upregulation of miR-96 promotes radioresistance in glioblastoma cells via targeting PDCD4
- (2018) Pin Guo et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a
- (2018) Yingxia Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Downregulation of lncRNA NEAT1_2 radiosensitizes hepatocellular carcinoma cells through regulation of miR-101-3p/WEE1 axis
- (2018) Xin Chen et al. CELL BIOLOGY INTERNATIONAL
- MiR-182 enhances radioresistance in non-small cell lung cancer cells by regulating FOXO3
- (2018) Gang Chen et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Large scale in vivo micro-RNA loss of function screen identified miR-29a, miR-100 and miR-155 as modulators of radioresistance and tumor-stroma communication
- (2018) Azadeh Fahim Golestaneh et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells
- (2018) Xiang Gao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Radiogenomics
- (2018) Michael D. Story et al. MEDICAL PHYSICS
- Long noncoding RNAs: emerging players in thyroid cancer pathogenesis
- (2017) Avaniyapuram Kannan Murugan et al. ENDOCRINE-RELATED CANCER
- Involvement of miR-155/FOXO3a and miR-222/PTEN in acquired radioresistance of colorectal cancer cell line
- (2017) Hamed Manoochehri Khoshinani et al. JAPANESE JOURNAL OF RADIOLOGY
- Involvement of miR-155/FOXO3a and miR-222/PTEN in acquired radioresistance of colorectal cancer cell line
- (2017) Hamed Manoochehri Khoshinani et al. Japanese Journal of Radiology
- LncRNA-SLC6A9-5:2: a potent sensitizer in 131I-resistant papillary thyroid carcinoma with PARP-1 induction
- (2017) Cheng Xiang et al. Oncotarget
- Consensus on the management of advanced radioactive iodine-refractory differentiated thyroid cancer on behalf of the Spanish Society of Endocrinology Thyroid Cancer Working Group (GTSEEN) and Spanish Rare Cancer Working Group (GETHI)
- (2016) J. Capdevila et al. Clinical & Translational Oncology
- MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1
- (2016) Min Kang et al. Cancer Medicine
- Inhibition of miR-146b expression increases radioiodine-sensitivity in poorly differential thyroid carcinoma via positively regulating NIS expression
- (2015) Luchuan Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differential expression levels of plasma-derived miR-146b and miR-155 in papillary thyroid cancer
- (2015) Yoon Se Lee et al. ORAL ONCOLOGY
- Low risk papillary thyroid cancer
- (2014) J. P. Brito et al. BMJ-British Medical Journal
- New developments in the diagnosis and treatment of thyroid cancer
- (2013) David F. Schneider et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Upregulated miR-155 in Papillary Thyroid Carcinoma Promotes Tumor Growth by Targeting APC and Activating Wnt/β-Catenin Signaling
- (2013) Xiaoping Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility
- (2008) Marina N. Nikiforova et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More